Brief Report: A Phase IIb Trial of a Novel Extended‐Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis

Conaghan, PG orcid.org/0000-0002-3478-5665, Cohen, SB, Berenbaum, F et al. (3 more authors) (2018) Brief Report: A Phase IIb Trial of a Novel Extended‐Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis. Arthritis and Rheumatology, 70 (2). pp. 204-211. ISSN 2326-5191

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017 The Authors. Arthritis & Rheumatology published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/
Dates:
  • Accepted: 24 October 2017
  • Published (online): 31 October 2017
  • Published: February 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 20 Oct 2017 15:35
Last Modified: 29 Mar 2018 11:11
Status: Published
Publisher: Wiley
Identification Number: https://doi.org/10.1002/art.40364

Share / Export

Statistics